News & Updates

Combination therapy with relugolix (once daily relugolix 40 mg, estradiol 1 mg, norethindrone acetate 0.5 mg) leads to improvement in heavy menstrual bleeding (HMB) and in other uterine fibroid (UF)-related symptoms independent of the location of the largest fibroid, results of a recent study have shown.

The risk of arterial thromboembolism, venous thromboembolism, and bleeding is higher in adults with nephrotic syndrome than the general population, a study has found. However, the mechanisms and consequences of this association warrant further research.

There appears to be a dearth of evidence on the management of nonrelaxing pelvic floor dysfunction (PFD), a debilitating condition characterized by tension of the pelvic floor muscles that frequently leads to pelvic pain, according to data presented at ACOG 2022.

Breast cancer patients see no excess risk of ischaemic heart disease (IHD)-related mortality after radiotherapy (RT) treatment, according to a recent Singapore study.

High intake of starchy foods appears to aggravate the risk of type 2 diabetes (T2D) in women, reports a recent Japan study.

Pelvic floor muscle exercises appear to exert favourable effects on urinary incontinence in men who have undergone prostate cancer surgery, according to a study.

The addition of ixazomib to cyclophosphamide-dexamethasone treatment does not seem to result in better survival and response rates in patients with newly diagnosed and relapsed multiple myeloma (MM), a recent study has found.